Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve. Our diverse, durable product portfolio is sold in more than 90 countries and serves animals across many species, primarily: dogs and cats (collectively, pet health) and cattle, poultry, swine and sheep (collectively, farm animal). Our purpose – making life better for animals makes life better – inspires us to Go Beyond for animals, our customers, our people and society. Go Beyond for Animals – Our strong portfolio, high-impact innovation, unique market approach and dedication to making life better allow us to go beyond for animals to address critical health needs and increase access to health products and services.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No related securities.
No related securities.
| Dec FY2016 | 2.9B |
|---|---|
| Dec FY2017 | 2.9B |
| Dec FY2018 | 3.1B |
| Dec FY2019 | 3.1B |
| Dec FY2020 | 3.3B |
| Dec FY2021 | 4.8B |
| Dec FY2022 | 4.4B |
| Dec FY2023 | 4.4B |
| Dec FY2024 | 4.4B |
| Dec FY2025 | 4.7B |
| Sep Q3 FY23 | 1.1B |
|---|---|
| Dec Q4 FY23 | 1B |
| Mar Q1 FY24 | 1.2B |
| Jun Q2 FY24 | 1.2B |
| Sep Q3 FY24 | 1B |
| Dec Q4 FY24 | 1B |
| Mar Q1 FY25 | 1.2B |
| Jun Q2 FY25 | 1.2B |
| Sep Q3 FY25 | 1.1B |
| Dec Q4 FY25 | 1.1B |
| Mar Q1 FY26 | 1.4B |
| Jun Q2 FY26 | 1.4B |